L2 Asset Management, LLC Merck & Co., Inc. Transaction History

L2 Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $180,731 - $210,592	1,596 Added 39.01%	5,687 $750,000
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $403,124 - $438,696	4,024 Added 6005.97%	4,091 $446,000
Q3 2023 Nov 08, 2023	SELL	$102.95 - $114.33 $1.11 Million - $1.23 Million	-10,752 Reduced 99.38%	67 $6,000
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $142,279 - $155,077	1,310 Added 13.78%	10,819 $1.25 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $637,919 - $711,787	6,197 Added 187.11%	9,509 $1.01 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $279,963 - $314,507	3,312 New	3,312 $285,000
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $408,506 - $464,834	-5,801 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $39,219 - $54,360	619 Added 11.95%	5,801 $446,000
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $402,019 - $453,632	5,182 New	5,182 $471,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on L2 Asset Management, LLC with notifications on news.